Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C9NX
|
|||
| Drug Name |
PMID29671355-Compound-59
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
REGENACY PHARMACEUTICALS, LLC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H23N5OS
|
|||
| Canonical SMILES |
C1CN(CCN1)C2=CC3=CN=C(C=C3C=C2)C(=O)NC4=C(C=CC(=C4)C5=CC=CS5)N
|
|||
| InChI |
1S/C24H23N5OS/c25-20-6-4-17(23-2-1-11-31-23)14-21(20)28-24(30)22-13-16-3-5-19(12-18(16)15-27-22)29-9-7-26-8-10-29/h1-6,11-15,26H,7-10,25H2,(H,28,30)
|
|||
| InChIKey |
SRWKZCCXNJSFMX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.